Literature DB >> 207421

Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.

M M Black, R E Zachrau, B Shore, A S Dion, H P Leis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207421

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  A human breast tumor cell line (BT-474) that supports mouse mammary tumor virus replication.

Authors:  E Y Lasfargues; W G Coutinho; A S Dion
Journal:  In Vitro       Date:  1979-09

2.  A human protein related to the major envelope protein of murine mammary tumor virus: identification and characterization.

Authors:  A S Dion; D C Farwell; A A Pomenti; A J Girardi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

3.  Radioimmunoassays for the 36,000-dalton glycoprotein of murine mammary tumor viruses demonstrate type, group, and interspecies determinants.

Authors:  Y A Teramoto; J Schlom
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

4.  Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis.

Authors:  Y T Lee; K M Sheikh; F P Quismorio; G J Friou
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Possible immunological implications of an association between the stages of first and second independent breast cancers.

Authors:  M M Black; B F Hankey; J L Aron; P C Prorok
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

6.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Authors:  D Colcher; P H Hand; M Nuti; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

7.  Generation of human monoclonal antibodies reactive with human mammary carcinoma cells.

Authors:  J Schlom; D Wunderlich; Y A Teramoto
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.